Overview
- Definition
Inflammatory multifocal chorioretinal disorder of unknown etiology affecting mainly young, healthy, myopic women
May be a subset of multifocal choroiditis and panuveitis (MCP)
- Symptoms
Loss of central acuity
Scotoma
Photopsia
Metamorphopsia
Photophobia
- Laterality
80% bilateral, but may be asymmetric
- Course
Self-limited over several months
Recurrence is less likely compared to MCP
New lesions are rare
Visual prognosis typically good in absence of CNV and subretinal fibrosis
Some cases progress to MCP
- Age of onset
Median of 30 years
- Gender/race
Predominantly female with varying degree of myopia
Caucasian
- Systemic association
Affected individuals are usually healthy
Exam: Ocular
Anterior Segment
No AC reaction
Posterior Segment
Little to no vitritis
- Small (100–200 μm diameter), discrete, yellowish lesions at inner choroid and RPE:
Limited to posterior pole, rarely extend to midperiphery
Become atrophic and punched out
New lesions are rare
- CNV:
Very common (40–75%)
Major cause of visual impairment
CME is uncommon
Exam: Systemic
None
Imaging
- OCT
RPE elevation with sub-RPE collections and compression of photoreceptor IS/OS junctions
- FA
Active lesions: early hyperfluorescence followed by variable late staining/leakage
Inactive lesions: window defects
- ICG
Hypolucent, corresponding to lesions on exam
- ERG
Normal
- Visual field/microperimetry
Helpful in monitoring for scotomata
Laboratory and Radiographic Testing
Chest Xray
ACE/lysozyme
FTA-ABS/RPR
PPD/QuantiFERON-TB Gold
Differential Diagnosis
- Multifocal choroiditis and panuveitis (MCP)
Chronic/recurrent course
More intraocular inflammation
Lesions more variable in size and extend beyond posterior pole
CME more common
ERG often abnormal
Presume Ocular histoplasmosis syndrome (POHS)
Multiple evanescent white dot syndrome (MEWDS)
Acute posterior multifocal placoid pigment epitheliopathy (APMPPE)
Subretinal fibrosis and uveitis (SFU)
Sarcoidosis
Myopic degeneration maculopathy
Toxoplasmosis
Lyme disease
Vogt-Koyanagi-Harada (VKH) syndrome
Treatment
Systemic and regional corticosteroids if lesion threatens fovea
IMT in rare, recurrent cases
CNV can be effectively treated with intravitreal anti-VEGF, PDT/verteporgin +/− intravitreal triamcinolone
Referral/Comanagement
None